VEGFA and Kaposi's sarcoma: In another study, RV, THMS, YuA-C (tested at 25 μM), exerted anti-inflammatory effects in vitro in Kaposi’s sarcoma (KS) cells induced by vascular endothelial growth factor (VEGF).